A supply chain generalized network oligopoly model for pharmaceuticals under brand differentiation and perishability

Transportation Research Part E: Logistics and Transportation Review

Volumn 48, Issue 4, 2012, Pages 762-780

  Masoumi, Amir H ^a   Yu, Min ^a   Nagurney, Anna ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Brand differentiation; Generalized network; Healthcare; Perishable products; Pharmaceutical companies; Supply chains

Indexed keywords

COMPETITION; DRUG PRODUCTS; VARIATIONAL TECHNIQUES;

BRAND DIFFERENTIATION; COURNOT COMPETITION; GENERALIZED NETWORKS; HEALTHCARE; OLIGOPOLY MODELS; PERISHABLE PRODUCT; PHARMACEUTICAL COMPANY; PHARMACEUTICAL PRODUCTS; PRODUCT FLOW; VARIATIONAL INEQUALITIES;

SUPPLY CHAINS;

COMPETITION (ECONOMICS); HEALTH CARE; MANUFACTURING; MODELING; OLIGOPOLY; PHARMACEUTICAL INDUSTRY;

EID: 84858119438     PISSN: 13665545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tre.2012.01.001     Document Type: Article

References (73)

1. Amaro A., Barbosa-Povoa A. Planning and scheduling of industrial supply chains with reverse flows: a real pharmaceutical case study. Computers & Chemical Engineering 2008, 32(11):2606-2625.
2. Bai R., Kendall G. A model for fresh produce shelf space allocation and inventory management with freshness condition dependent demand. INFORMS Journal on Computing 2008, 20(1):78-85.
3. Blackburn J., Scudder G. Supply chain strategies for perishable products: the case of fresh produce. Production and Operations Management 2009, 18:129-137.
4. Boulaksil, Y., 2009. Planning of Outsourced Operations in Pharmaceutical Supply Chains. PhD Thesis in Operations Management and Logistics, The BETA Research School, The Netherlands.
5. Breen L., Crawford H. Improving the pharmaceutical supply chain: assessing the reality of e-quality through e-commerce application in hospital pharmacy. International Journal of Quality & Reliability Management 2005, 22(6):572-590.
6. Business Wire, 2009. CVS has consumers going nuts over expired milk, eggs, infant formula, medicine, according to Change to Win. April 2. <>. http://www.businesswire.com/news/google/20090402006264/en.
7. Cournot A.A. Researches into the Mathematical Principles of the Theory of Wealth, English Translation 1838, MacMillan, London, England.
8. Dafermos S., Nagurney A. Oligopolistic and competitive behavior of spatially separated markets. Regional Science and Urban Economics 1987, 17:245-254.
9. De la Garza, D., 2011. Pharmaceutical patent protection and why 2012 is the year companies fear the most. The Strategic Sourceror, September 1. <>. http://www.strategicsourceror.com/2011/09/pharmaceutical-patent-protection-and.html.
10. Deo S., Corbett C.J. Cournot competition under yield uncertainty: the case of the U.S. influenza vaccine market. Manufacturing & Service Operations Management 2009, 11(4):563-576.
11. Dunehew A. Changing dynamics in the pharmaceutical supply chains: a GPO perspective. American Journal of Health - System Pharmacy 2005, 62:527-529.
12. Dupuis P., Nagurney A. Dynamical systems and variational inequalities. Annals of Operations Research 1993, 44:9-42.
13. Emanuel, E., 2011. Shortchanging cancer patients. The New York Times, August 6. <>. http://www.nytimes.com/2011/08/07/opinion/sunday/ezekiel-emanuel-cancer-patients.html.
14. Enyinda, C., Briggs, C., Bachkar, K., 2009. Managing risk in pharmaceutical global supply chain outsourcing: Applying analytic hierarchy process model. In: Proceedings of American Society of Business and Behavioral Sciences (ASBBS) Annual Conference 16(1), Las Vegas, Nevada.
15. Gabay D., Moulin H. On the uniqueness and stability of Nash equilibria in noncooperative games. Applied Stochastic Control of Econometrics and Management Science 1980, 271-294. North-Holland, Amsterdam, The Netherlands. A. Bensoussan, P. Kleindorfer, C.S. Tapiero (Eds.).
16. Gatica G., Papageorgiou L., Shah N. Capacity planning under uncertainty for the pharmaceutical industry. Chemical Engineering Research and Design 2003, 81(6):665-678.
17. Goyal S.K., Giri B.C. Recent trends in modeling of deteriorating inventory. European Journal of Operational Research 2001, 134:1-16.
18. Grocery Manufacturers of America, 2004. 2004 unsalables benchmark report. <>. http://www.gmabrands.com/industryaffairs/docs/benchgma2004.pdf.
19. Harris, G., 2011. Deal in place for inspecting foreign drugs. The New York Times, August 13. <>. http://www.nytimes.com/2011/08/13/science/13drug.html?scp=1&sq=deal%20in%20place%20for%20inspecting%20foreign%20drugs&st=cse.
20. Harvard Medical School, 2003. Drug Expiration Dates - Do They Mean Anything? The Harvard Medical School Family Health Guide.
21. Hernando M., Mezcua M., Fernandez-Alba A., Barcelo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69(2):334-342.
22. IBM, 2004. Pharma 2010: The Value-Creating Supply Chain. IBM Business Consulting Services.
23. Jesson J., Pocock R., Wilson K. Reducing medicines waste in the community. Primary Health Care Research and Development 2005, 6:117-124.
24. Johnson, T., 2011. The debate over generic-drug trade. Council on Foreign Relations, August 3. <>. http://www.cfr.org/drugs/debate-over-generic-drug-trade/p18055#p2.
25. Karaesmen I., Scheller-Wolf A., Deniz B. Managing perishable and aging inventories: review and future research directions. Planning Production and Inventories in the Extended Enterprise 2011, 393-436. Springer, Berlin, Germany. K. Kempf, P. Keskinocak, P. Uzsoy (Eds.).
26. Kinderlehrer D., Stampacchia G. An Introduction to Variational Inequalities and Their Applications 1980, Academic Press, New York.
27. Liu Z., Nagurney A. Supply chain outsourcing under exchange rate risk and competition. Omega 2011, 39:539-549.
28. Liu, Z., Nagurney, A., in press. Multiperiod competitive supply chain networks with inventorying and a transportation network equilibrium reformulation. Optimization and Engineering. doi:10.1007/s11081-011-9170-2.
29. Marucheck A., Greis N., Mena C., Cai L. Product safety and security in the global supply chain: issues, challenges and research opportunities. Journal of Operations Management 2011, 29:707-720.
30. Mendoza, M., 2008. More testing for drugs in water sought. USA Today, March 3. <.>. http://www.usatoday.com/news/nation/2008-03-16-3533657499_x.htm.
31. Mihalopoulos, D., 2009. Expired or lost drugs costing city $1 million. Chicago Tribune, February 3.
32. Muller, J., Popke, C., Urbat, M., Zeier, A., Plattner, H., 2009. A simulation of the pharmaceutical supply chain to provide realistic test data. In: First International Conference on Advances in System Simulation, Porto, Portugal.
33. Nagurney A. The formulation and solution of large-scale multicommodity equilibrium problems over space and time. European Journal of Operations Research 1989, 42:166-177.
34. Nagurney A. Network Economics: A Variational Inequality Approach 1999, Kluwer Academic Publishers, Boston, Massachusetts. second and revised ed.
35. Nagurney A. Supply Chain Network Economics: Dynamics of Prices, Flows and Profits 2006, Edward Elgar Publishing Inc., Cheltenham, UK.
36. Nagurney A. Supply chain network design under profit maximization and oligopolistic competition. Transportation Research Part E 2010, 46:281-294.
37. Nagurney A. Formulation and analysis of horizontal mergers among oligopolistic firms with insights into the merger paradox: a supply chain network perspective. Computational Management Science 2010, 7:377-401.
38. Nagurney A., Aronson J. A general dynamic spatial price network equilibrium model with gains and losses. Networks 1989, 19(7):751-769.
39. Nagurney, A., Masoumi, A.H., 2012. Supply chain network design of a sustainable blood banking system. In: Boone, T., Jayaraman, V., Ganeshan, R. (Eds.), Sustainable Supply Chains: Models, Methods and Public Policy Implications, Springer, London, England.
40. Nagurney, A., Nagurney, L., 2011. Medical nuclear supply chain design: a tractable network model and computational approach. June 2011.
41. Nagurney A., Yu M. Sustainable fashion supply chain management under oligopolistic competition and brand differentiation. International Journal of Production Economics 2012, 135:532-540.
42. Nagurney A., Zhang D. Projected Dynamical Systems and Variational Inequalities with Applications 1996, Kluwer Academic Publishers, Norwell, Massachusetts.
43. Nagurney A., Dupuis P., Zhang D. A dynamical systems approach for network oligopolies and variational inequalities. Annals of Regional Science 1994, 28:263-283.
44. Nagurney A., Yu M., Qiang Q. Supply chain network design for critical needs with outsourcing. Papers in Regional Science 2011, 90:123-142.
45. Nagurney, A., Masoumi, A.H., Yu, M., in press. Supply chain network operations management of a blood banking system with cost and risk minimization. Computational Management Science. doi:10.1007/s10287-011-0133-z.
46. Nahmias S. Perishable Inventory Systems 2011, Springer, New York.
47. Nash J.F. Equilibrium points in n-person games. Proceedings of the National Academy of Sciences, USA 1950, 36:48-49.
48. Nash J.F. Noncooperative games. Annals of Mathematics 1951, 54:286-298.
49. Niziolek, L., 2008. A simulation-based study of distribution strategies for pharmaceutical supply chains. PhD Thesis in Industrial Engineering, Purdue University, Indiana.
50. Papageorgiou L. Supply chain optimisation for the process industries: advances and opportunities. Computers and Chemical Engineering 2009, 33:1931-1938.
51. Papageorgiou L., Rotstein G., Shah N. Strategic supply chain optimization for the pharmaceutical industries. Industrial & Engineering Chemistry Research 2001, 40:275-286.
52. Rossetti C.L., Handfield R., Dooley K.J. Forces, trends, and decisions in pharmaceutical supply chain management. International Journal of Physical Distribution & Logistics Management 2011, 41:601-622.
53. Rossi, K., 2011. Several prescription drug patents set to expire. September 13. <>. http://www.krtv.com/news/several-prescription-drug-patents-set-to-expire.
54. Schapranow, M., Zeier, A., Plattner, H., 2011. A formal model for enabling RFID in pharmaceutical supply chains. In: Proceedings of the 44th Hawaii International Conference on System Sciences.
55. Schneider, M., 2011. Profiteers take advantage of drug shortages. Family Practice News, August 16. <>. http://www.familypracticenews.com/news/more-top-news/single-view/profiteers-take-advantage-of-drug-shortages/c5d7e6858b.html.
56. Schwab B., Hayes E., Fiori J., Mastrocco F., Roden N., Cragin D., Meyerhoff R., D'Aco V., Anderson P. Human pharmaceuticals in US surface waters: a human health risk assessment. Regulatory Toxicology and Pharmacology 2005, 42(3):296-312.
57. Shah N. Pharmaceutical supply chains: key issues and strategies for optimisation. Computers and Chemical Engineering 2004, 28:929-941.
58. Sheu J.-B., Talley W.K. Green supply chain management: trends, challenges, and solutions. Transportation Research Part E 2011, 47(6):791-792.
59. Smith, A., 2011. Sanofi wins Lipitor licence from Pfizer. Healthcare Global, September 1. <>. http://www.healthcareglobal.com/finance_insurance/sanofi-wins-lipitor-licence-from-pfizer.
60. Sousa R., Shah N., Papageorgiou L. Supply chain design and multilevel planning: an industrial case. Computers and Chemical Engineering 2008, 32:2643-2663.
61. Subramanian D., Pekny J., Reklaitis G. A simulation-optimization framework for research and development pipeline management. American Institute of Chemical Engineers Journal 2001, 47(10):2226-2242.
62. Szabo, L., 2011. Drug shortages set to reach record levels. USA Today, August 15. <.>. http://yourlife.usatoday.com/health/story/2011/08/Drug-shortages-set-to-reach-record-levels/49984446/1.
63. The Health Strategies Consultancy LLC, 2005. Follow the Pill: Understanding the US Commercial Pharmaceutical Supply Chain. Prepared for the Kaiser Family Foundation, March.
64. Tsiakis P., Papageorgiou L. Optimal production allocation and distribution supply chain networks. International Journal of Production Economics 2008, 111:468-483.
65. WABC, 2008. AG: pharmacies selling expired products. June 12. <>. http://abclocal.go.com/wabc/story?section=news/local&id=6201355.
66. Wall Street Journal, 2011. US job cuts surge 60% in July on month - challenger report. Dow Jones Newswires, August 3. <>. http://online.wsj.com/article/BT-CO-20110803-707866.html.
67. Wiggins S.N., Maness R. Price competition in pharmaceuticals: the case of anti-invectives. Economic Inquiry 2004, 42(2):247-263.
68. Wolf, A., 2011. Merck set to lay off 13,000. News Observer, July 30. <>. http://www.newsobserver.com/2011/07/30/1378418/merck-set-to-lay-off-13000.html.
69. WPRI, 2009. CVS offers $2 for expired products. June 11. <>. http://www.wpri.com/dpp/news/local_news/local_wpri_money_for_expired_products_in_ca_pharmacies_20090611.
70. Yost R. New economics of the pharmaceutical supply chain. American Journal of Health - System Pharmacy 2005, 62:525-526.
71. Yue, D., Wu, X., Bai, J., 2008. RFID application framework for pharmaceutical supply chain. In: Proceedings of IEEE International Conference on Service Operations and Logistics, and Informatics. Beijing, China. p. 1125-30.
72. Yu X., Li C., Shi Y., Yu M. Pharmaceutical supply chain in China: current issues and implications for health system reform. Health Policy 2010, 97:8-15.
73. Zacks Equity Research, 2011. Pharmaceutical Industry Outlook - March 2011.